Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
POMDOCTOR Ltd

POMDOCTOR Ltd (POM) Stock Overview

Explore POMDOCTOR Ltd’s financial performance, market position, analyst ratings, and future outlook.

POM●NASDAQ
HealthcareMedical - Pharmaceuticals
$1.09
$0.23(26.01%)
U.S. Market opens in 11h 44m

POMDOCTOR Ltd (POM)

Meyka AI Score

Z

Key Financials

Market Cap7.3M
P/E Ratio-1.69
EPS (TTM)$-5.03
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$-1.62
3 Months$0.00
1 Year Target$0.00

POM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of POMDOCTOR Ltd (NASDAQ: POM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, POMDOCTOR Ltd's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of POM on the NASDAQ shows an RSI of 53.28, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind POMDOCTOR Ltd's NASDAQ-traded stock include a P/E ratio of -1.69 and a market capitalization of 7.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of POM on the NASDAQ.

Price Performance (NASDAQ: POM)

1-Day Change
24.87%
5-Day Change
55.86%
1-Month Change
-29.41%
3-Month Change
-19.99%
6-Month Change
-73.91%
Year-to-Date (YTD) Change
-79.66%
1-Year Change
-98.51%
3-Year Change
-98.51%
5-Year Change
-98.51%
All-Time (Max) Change
-98.51%

Contact Information

https://www.7lk.com
86 20 6231 2277
Yongxu Industrial Park, Guangzhou, GD, 510000

Company Facts

1,650 Employees
IPO DateOct 8, 2025
CountryCN
Actively Trading

Frequently Asked Questions